This review summarizes important studies regarding Helicobacter pylori therapy published
from April 2019 to April 2020. The main themes that emerge involve studies assessing …

The Gram-negative bacterium Helicobacter pylori colonizes ca 50% of human stomachs
worldwide and is the major risk factor for gastric adenocarcinoma. Its high genetic variability …

For the first time since 2015, the World Health Organization's (WHO) global Antimicrobial
Resistance and Use Surveillance (GLASS) featured both global reports for antimicrobial …

Background Knowledge of global clarithromycin (CLA)-resistant rates of Helicobacter pylori
(H. pylori) is crucial for decision of the most appropriate eradication therapies with good …

Abstract Background The role of Helicobacter pylori (H. pylori) virulence factors of such as
vacA s1m1 and cagA in designating clinical outcomes and eradication rate has been deeply …

Helicobacter pylori as a class I carcinogen is correlated with a variety of severe
gastroduodenal diseases; therefore, H. pylori eradication has become a priority to prevent …

Strains of Helicobacter pylori (H. pylori) resistant to various antibiotics have increased in
recent years. In this context, the search for new therapeutic approaches is crucial. The aim of …

Antimicrobial resistance (AMR) in Helicobacter pylori is increasing and can result in
treatment failure and inappropriate antibiotic usage. This study used whole genome …

The current study was conducted to assess the prevalence and odds ratio (OR) of co-
infection of Helicobacter pylori (H. pylori) and intestinal parasites (IPs). English databases …

In the present study, we aimed to investigate the modulatory effects of a potential probiotic
bacterium Lactobacillus gasseri ATCC 33323 on Helicobacter pylori-induced inflammatory …